Cargando…
Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions
Adeno-associated virus (AAV) vectors are one of the most efficient in vivo gene delivery platforms. Over the past decade, clinical trials of AAV vector-mediated gene transfer led to some of the most exciting results in the field of gene therapy and, recently, to the market approval of an AAV-based d...
Autores principales: | Basner-Tschakarjan, Etiena, Mingozzi, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107954/ https://www.ncbi.nlm.nih.gov/pubmed/25101090 http://dx.doi.org/10.3389/fimmu.2014.00350 |
Ejemplares similares
-
Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014) -
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015) -
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020) -
Modulation of CD8(+) T cell responses to AAV vectors with IgG-derived MHC class II epitopes
por: Hui, Daniel J, et al.
Publicado: (2013) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)